InvestorsHub Logo
Followers 0
Posts 2393
Boards Moderated 0
Alias Born 09/22/2012

Re: Drs136 post# 18074

Saturday, 05/23/2015 3:50:00 PM

Saturday, May 23, 2015 3:50:00 PM

Post# of 20775
TY for the compliment.Man its been a hard ride since 3 events occured the summer of 2012 Blech,Pfizer pulling the plug on the A/D phase III trial and then Pfizer reneged on the milestone payment which then caused our past scientist/CEO to throw his hands up and walk away in early 2013 and all the ligation that occured.

Still totaly disagree with the insiders owners for placing a scientist as the CEO/Chairman long ago.To me that was a momentum business mistake.Chain is a great scientist no question about that but not the only one on the planet.

Dont think it would have mattered who was driving.This was a speeding bullet there was going to one heck of a wreck which occured when the restructure,reverse split occured.

There was a complete change of ownership/control and we now have a true qualified business man as our new Chairman/CEO.To me that was the first correct move insiders made in years.

Very low share structure 3.3 million o/s so if something positive occurs we should recover something.Who knows maybe even make a few dollars.

Last I heard from our CEO was friday.He is waiting like we all are for Shire to officially complete the trial.Don't know if they finished enrolling last small group maybe difficult to find patients being a rare disease.

Nothing we don't already know cause we all can check the status of the trial at anytime link provided.

https://www.clinicaltrials.gov/ct2/show/NCT01898884?term=vp20629&rank=1

I'm not even in the ballpark when it comes to business as Elliot is.Heck most likely not even in the parking lot outside the ballpark.I'm sure not a scientist either.

A man must know his limitations.



Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.